While the majority of cerebral ischemic events due to carotid occlusive disease result from atherosclerotic plaque rupture, intraluminal carotid artery thrombus occasionally occurs in patients without preexisting carotid atherosclerosis. Identification of nonatherosclerotic thrombus as the cause of the carotid occlusive disease can obviate the need for an interventional procedure, and resolution of thrombus can be monitored with B-mode duplex ultrasonography. METHODS: We reviewed 3 patients treated on The Mount Sinai Hospital Stroke Unit with anticoagulation for nonatherosclerotic carotid thrombi and followed with serial Doppler ultrasonogrpahy for resolution of thrombus. RESULTS: Occlusive carotid thrombus was successfully treated in all 3 patients with systemic anticoagulation. B-mode duplex ultrasonography allowed for demonstration of resolving thrombus. CONCLUSION: Differentiation between a stenotic plaque and occlusive thrombus can be achieved by ultrasonographic analysis of thrombus morphology, attachment site potential, and characteristics of a resolving thrombus. Systemic anticoagulation can safely and effectively eliminate the risk for future embolization and complete occlusion of the carotid artery in patients who present with transient ischemic events or completed infarcts of small size.
Introduction
Most cerebral ischemic events due to carotid artery occlusive disease result from atherosclerotic plaque rupture. However, occasionally carotid occlusions are identified in patients without significant carotid atherosclerosis. The exact incidence of nonatherosclerotic thrombi is not known, but rates from .05-.5% have been cited in the literature. [1] [2] [3] In the North American Symptomatic Carotid Endarterectomy (NASCET) trial, intraluminal carotid artery thrombus occurred in 1.1% of patients with <70% stenosis. 4 At times these nonatherosclerotic carotid thrombi are found to be associated with a hypercoaguable states or inflammatory disorders. 1, 5 The optimal management for nonatherosclerotic occlusive thrombi remains controversial, but has included antiplatelet or anticoagulant with or without delayed revascularization as well as urgent revasculation. [1] [2] [3] 5, 6 Surgical management of occlusive thrombi carries the potential risk of stroke from thrombus dislodgement. The absolute risk of stroke in patients with nonatherosclerotic carotid thrombi undergoing intervention is not known, given the infrequency with which these procedures occur. 1 However, in patients with atherosclerotic carotid disease, endarterectomy and stenting are both associated with periprocedural complicatrions. 4, 7 Our ability to demonstrate resolving thrombi on duplex ultrasonography in 3 patients treated with systemic anticoagulation helps identify patients who can be treated with a noninterventional approach.
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Methods
Three cases of patients treated on Mount Sinai Hospital Stroke Unit with anticoagulation for nonatherosclerotic carotid thrombi and followed with serial Doppler ultrasonogrpahy for resolution of thrombus were reviewed. These patients were not considered for acute endovascular intervention, as two presented after resolution of transient symptoms and one presented with established infarct on computed tomography (CT). In each case, the thrombus was present without an underlying plaque. Each patient had successful resolution of carotid thrombus with systemic anticoagulation and no progression of neurologic deficits.
At our institution, the degree of stenosis on computerized tomographic angiography (CTA) and magnetic resonance angiography (MRA) is measured by NASCET criteria. Percentage of stenosis on Doppler is based on frequency shift and calculated velocity of the Doppler signal that is proportional to the area of the residual lumen, not the measurement of stenosis and internal diameter on the ultrasound, which is variable. Stenosis is reported in ranges as required by the Intersocietal Accreditation Commission (IAC). The range is established by correlating the results of duplex studies to angiography, CTA, and MRA according to IAC standards.
Results
Patient 1
A 73-year-old man with atrial fibrillation, lung cancer, and a prior right lobectomy who presented with a transient episode of left-sided hemiparesis and left facial droop lasting 30 minutes. The patient was referred by his cardiologist, who suspected a cerebral embolic event from underlying atrial fibrillation, and he was considered high surgical risk because of his previous lobectomy. As seen in Figure 1 , duplex ultrasonography demonstrated a nearly occluding thrombus in the distal right common carotid artery (CCA) extending into the right internal carotid artery (ICA), without underlying plaque. The carotid thrombus was confirmed on CTA, which demonstrated a string sign in the distal CCA. MRI showed punctate infarcts in the right posterior middle cerebral artery territory that presented minimal risk of hemorrhagic conversion on anticoagulation. The patient was admitted and started on a heparin drip. The patient was followed with serial duplex ultrasonography every four days. Four days after initiating anticoagulation, there was 70-99% stenosis, and eight days later 20-49% stenosis. The patient's atrial fibrillation was the presumed source of his thrombus. He was transitioned to warfarin and discharged with a normal neurologic exam after the first duplex ultrasound showed improvement in the thrombosis.
Patient 2
A 48-year-old man with human immunodeficiency virus (HIV), hypertension, and avascular necrosis of the femoral head requiring left hip replacement two weeks prior presented after two episodes of transient right hand and face tingling and weakness lasting 5 to 10 minutes. On his initial examination, he had flattening of the right nasolabial fold but was otherwise neurologically normal. CT head (CTH) was unremarkable. CTA of the head and neck was notable for an unusual plaque of the left CCA. Duplex ultrasonography, as shown in Figure 2 , confirmed a thrombus in the mid-CCA with no associated plaque. MRI revealed a small left-sided watershed infarct at low risk of hemorrhagic conversion. The patient was started on a heparin drip. The patient was noted to have a thrombocytosis of more than 1 million. A hematology consultation supported that the thrombosis occurred in the setting of a reactive thrombocytosis from hip replacement two weeks prior to admission. The patient had no further episodes of transient neurologic dysfunction. Repeat duplex ultrasonography showed resolution of the left carotid thrombus, and repeat MRI did not show any additional infarcts. Heparin drip was stopped and the patient was maintained on aspirin 81mg daily. At the time of discharge, the patient remained neurologically normal.
Patient 3
A 61-year-old man with hypertension, hyperlipidemia, and congestive heart failure presented with dizziness, headache, and confusion. CTH demonstrated a left parietal infarct. Initial examination revealed difficulty with receptive language, 4/5 strength in the right lower extremity, drift of the right upper extremity, and extinction to double simultaneous stimulation. CTA revealed a clot in the left ICA, which was confirmed on the duplex ultrasonography, as shown in Figure  3 . Again, there was no associated plaque. The patient was started on a heparin drip. Transthoracic and transesophageal echocardiograms did not reveal a source of thrombus. Extensive laboratory testing, including hypercoagulability panel, did not demonstrate a thrombophilia. A loop recorder was placed to monitor for paroxysmal atrial fibrillation given the high suspicion for a cardioembolic source. His speech and right-sided strength improved such that he was only left with mild drift of the right upper extremity. He was discharged on lovenox. Approximately three weeks later, repeat carotid Doppler showed near resolution of the thrombus, with only a small 1.9 mm lucency remaining, and approximately two months after presentation, the thrombus had completely resolved.
Discussion
Identification of nonatherosclerotic thrombus as the cause of the carotid occlusive disease can obviate the need for an interventional procedure and resolution of thrombus can be monitored with B-mode duplex ultrasonography. Thrombus resolution demonstrated by ultrasound was first presented as an abstract at the 2011 Society of Neuroimaging meeting. 10 Although a stenotic plaque and occlusive thrombus both have similarly elevated conduction velocities, an understanding of thrombus morphology and attachment site potential allows for differentiation. In each of the cases presented, the absence of an underlying plaque directly associated with the thrombus helped confirm the presence of the clot without arteriopathy. As demonstrated in Figures 1 and 2 , the acute thrombus is a low-density structure that reflects the ultrasound beam. The subacute thrombus is echolucent and is outlined by the color flow stream on duplex ultrasound. This transition from the acute to the subacute thrombus, and then the gradual resolution of the thrombus, which is clearly demonstrated with duplex ultrasound, is consistent in each case presented. The clot evolution in each case is similar and can help other demonstrate response to conservative treatment.
In each of these cases, duplex ultrasonography was performed urgently so that the mechanism of stroke could be identified and an appropriate intervention undertaken. Because of the small size of infarct, risk of further embolization, and risk of clot propagation producing total occlusion, the decision was made to anticoagulate these patients acutely. In each case, the clot resolved and no further neurologic events occurred. Notably, in each of these cases, duplex ultrasound was used in conjunction with other imaging modalities, including CTA. Duplex ultrasonography can be useful in elucidating CTA findings and presents no additional risk to patients.
Aside from being used to elucidate imaging findings of other modalities in a noninvasive way, duplex ultrasonography might be useful in patients with characteristics concerning for nonatherosclerotic thrombi. Bösel et al in their series of nonatherosclerotic carotid thrombi managed surgically have suggested that patients with nonatherosclerotic carotid thrombi are typically younger, lack the most common vascular risk factors and atherosclerosis, have a thrombogenic predisposition, and present with minor strokes or TIAs. 1 Given that patients with nonatherosclerotic carotid thrombi often present without typical vascular risk factors, thorough investigation of the possible underlying mechanism for thrombus formation must be undertaken.
There may indications for treatment of carotid thrombi with anticoagulation. Hisanao et al have reported successful resolution of an atherosclerotic carotid thrombus treated with dabigatran. 9 Combe et al describe 6 patients with carotid thrombi, including thrombi that were atheromatous, associated with an ulcerated plaque, and dissection, successfully treated with intravenous heparin.
11 Yet, others have described atherosclerotic thrombi with spontaneous resolution. 12 The 2 patients in this case series without underlying atrial fibrillation were treated with anticoagulation, although treatment with antiplatelet therapy may have been equally efficacious. As demonstrated in the Cervical Artery Dissection in Stroke Study, antiplatelet and anticoagulant therapies are equivalent in treating patients with nonatherosclerotic occlusions from dissection. 13 Further study of cases of carotid thrombi may reveal thrombus properties that favor one noninterventional treatment approach over another.
Our ability to demonstrate resolution of occlusive carotid thrombus on duplex ultrasonography supports a noninterventional approach to managing more patients with carotid thrombi and no arteriopathy. Despite the frequent use of CTA and MRA today, duplex ultrasound is a safe and effective way to quickly identify, follow, and guide therapy for intraluminal carotid clot, and it may be an underutilized procedure.
